Phibro Animal Health CorporationPAHCNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR-4.8%
5Y CAGR-12.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-4.8%/yr
Quarterly compound
5Y CAGR
-12.7%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.62% |
| Q3 2025 | 42.03% |
| Q2 2025 | 0.61% |
| Q1 2025 | 31.26% |
| Q4 2024 | 44.26% |
| Q3 2024 | -3.89% |
| Q2 2024 | -7.57% |
| Q1 2024 | 26.90% |
| Q4 2023 | 2262.67% |
| Q3 2023 | -103.05% |
| Q2 2023 | 28.10% |
| Q1 2023 | 17.10% |
| Q4 2022 | 15.78% |
| Q3 2022 | -40.21% |
| Q2 2022 | 19.24% |
| Q1 2022 | -13.91% |
| Q4 2021 | 52.57% |
| Q3 2021 | -23.73% |
| Q2 2021 | -4.84% |
| Q1 2021 | 1.22% |
| Q4 2020 | 26.78% |
| Q3 2020 | -13.42% |
| Q2 2020 | -15.01% |
| Q1 2020 | 8.72% |
| Q4 2019 | 93.25% |
| Q3 2019 | -16.14% |
| Q2 2019 | -46.38% |
| Q1 2019 | -12.21% |
| Q4 2018 | 12.48% |
| Q3 2018 | -12.44% |
| Q2 2018 | -1.48% |
| Q1 2018 | 10.67% |
| Q4 2017 | 6.93% |
| Q3 2017 | -4.74% |
| Q2 2017 | -21.60% |
| Q1 2017 | 32.46% |
| Q4 2016 | 3.74% |
| Q3 2016 | 8.52% |
| Q2 2016 | -5.06% |
| Q1 2016 | -6.41% |